CLN +14% to 5.00 on news - CLN spiking on news - 9:24 AM EDT April 18, 2007
CELSION CORPORATION (AMEX:CLN) today announced that it has entered into an Asset Purchase Agreement under which Boston Scientific Corporation (NYSE:BSX) will purchase the Company's Prolieve assets for $60 million, subject to reduction under certain circumstances. The Asset Purchase Agreement contains customary terms and conditions, including approval by Celsion's stockholders.